Evidence Hub

3D bioprinting biomimetic small intestinal microtissue-based molecularly imprinted electrochemical sensor for sensitive detection of ovalbumin

Ye L, Yu Y, Xu D, Feng Z, Mao L, Wang L, Jiang D

Bioelectrochemistry (Amsterdam, Netherlands), 2026

Abstract

This study presents a novel sensing strategy for ovalbumin (OVA) by integrating a controllable molecularly imprinted polymer (MIP) fabrication technique with three-dimensional (3D) bioprinting technology. A MIP with high specificity and affinity was designed and synthesized for OVA using the reverse microemulsion epitope-directed surface imprinting and coating (ROSIC) method with silylating monomers. The synthesized MIP was then innovatively incorporated into gelatin methacryloyl (GelMA) and uesd as bioink to 3D bioprint a biomimetic small intestinal microtissue, which was subsequently assembled into a working electrode. Together with a homemade Ag/AgCl reference electrode and a platinum wire counter electrode, the resulting interface formed a three-electrode electrochemical sensing system for OVA detection. The constructed sensor exhibited a linear response to OVA concentration in the range of 10-400 pg/mL. The standard curve equation was Ret = 11.12 COVA (pg/mL) + 3261.9, with a correlation coefficient R2 of 0.998, and a detection limit of 5.54 pg/mL.

How strong is the evidence?

Evidence Hub reads this as a experimental / empirical study, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free